Cargando…

Expression of CA125 in pancreatic carcinoma and chronic pancreatitis.

Detalles Bibliográficos
Autores principales:	Macdonald, F., Downing, R., Allum, W. H.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1988
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2246801/ https://www.ncbi.nlm.nih.gov/pubmed/3207606

Ejemplares similares

Ca 125 is an independent prognostic marker in resected pancreatic cancer of the head of the pancreas
por: Napoli, Niccolò, et al.
Publicado: (2023)

Tumour marker antigen CA125 in pancreatic cancer: a comparison with CA19-9 and CEA.
por: Haglund, C.
Publicado: (1986)

CA 125 concentration in portal blood as a predictor of resectability in pancreatic tumor
por: Szwedziak, Krzysztof, et al.
Publicado: (2013)

A Panel of CA19-9, Ca125, and Ca15-3 as the Enhanced Test for the Differential Diagnosis of the Pancreatic Lesion
por: Hogendorf, Piotr, et al.
Publicado: (2017)

Comparative study of CA242 and CA19-9 in chronic pancreatitis.
por: Furuya, N., et al.
Publicado: (1996)

The CA125 level postoperative change rule and its prognostic significance in patients with resectable pancreatic cancer
por: Luo, Xin, et al.
Publicado: (2023)

Serum CA125 is a novel predictive marker for pancreatic cancer metastasis and correlates with the metastasis-associated burden
por: Liu, Liang, et al.
Publicado: (2016)

Diagnostic Evaluation of Pancreatic Carcinoma and Chronic Pancreatitis by Pancreatoscopy
por: Tajiri, Hisao
Publicado: (1997)

Preoperative Serum CA125 Levels Predict the Prognosis in Hyperbilirubinemia Patients With Resectable Pancreatic Ductal Adenocarcinoma
por: Chen, Tao, et al.
Publicado: (2015)

Significance of mesothelin and CA125 expression in endometrial carcinoma: a retrospective analysis
por: Kakimoto, Soichiro, et al.
Publicado: (2021)

The investigation of (125)I seed implantation as a salvage modality for unresectable pancreatic carcinoma
por: Wang, Hao, et al.
Publicado: (2013)

Elevated CA125 levels in patients with metastatic breast carcinoma.
por: Perey, L., et al.
Publicado: (1990)

Intraoperative ultrasound-guided iodine-125 seed implantation for unresectable pancreatic carcinoma
por: Wang, Junjie, et al.
Publicado: (2009)

Peritoneal trauma releases CA125?
por: Redman, C. W., et al.
Publicado: (1988)

Diagnostic Accuracy of a CA125-Based Biomarker Panel in Patients with Pancreatic Cancer: A Systematic Review and Meta-Analysis
por: Meng, Qingcai, et al.
Publicado: (2017)

Mesothelin Binding to CA125/MUC16 Promotes Pancreatic Cancer Cell Motility and Invasion via MMP-7 Activation
por: Chen, Shih-Hsun, et al.
Publicado: (2013)

The clinical correlates of serum CA125 in 169 patients with epithelial ovarian carcinoma.
por: Hawkins, R. E., et al.
Publicado: (1989)

The prognostic value of pretreatment CA-125 levels and CA-125 normalization in ovarian clear cell carcinoma: a two-academic-institute study
por: Bai, Huimin, et al.
Publicado: (2016)

Comparison of Iodine-125 Seed Implantation and Pancreaticoduodenectomy in the Treatment of Pancreatic Cancer
por: Liu, Kai, et al.
Publicado: (2014)

The prognostic value of early CA125 serum assay in epithelial ovarian carcinoma.
por: Fisken, J., et al.
Publicado: (1993)

A Suspicious Pancreatic Mass in Chronic Pancreatitis: Pancreatic Actinomycosis
por: de Clerck, F., et al.
Publicado: (2015)

The role of Ca(2+) in the pathophysiology of pancreatitis
por: Gerasimenko, Julia V, et al.
Publicado: (2014)

Prognostic significance of preoperative serum CA125, CA19-9 and CEA in gastric carcinoma
por: Wang, Wei, et al.
Publicado: (2016)

Oncological markers CA-125, CA 19-9 and endometriosis
por: Fiala, Ludek, et al.
Publicado: (2018)

Comparative study of CA242 and CA19-9 for the diagnosis of pancreatic cancer.
por: Kawa, S., et al.
Publicado: (1994)

Chronic Pancreatitis in Bristol
por: Fedail, Sulieman S., et al.
Publicado: (1983)

Multi-modality imaging features distinguish pancreatic carcinoma from mass-forming chronic pancreatitis of the pancreatic head
por: Ruan, Zhibing, et al.
Publicado: (2018)

Ca(2+) Signaling and Its Potential Targeting in Pancreatic Ductal Carcinoma
por: Bettaieb, Louay, et al.
Publicado: (2021)

Exploring the Glycosylation of Serum CA125
por: Saldova, Radka, et al.
Publicado: (2013)

Ultrasound assessment of ovarian cancer risk in postmenopausal women with CA125 elevation
por: Menon, U, et al.
Publicado: (1999)

The Predictive Value of CA-125 and Hb for Ocular Metastasis in Hepatocellular Carcinoma Patients
por: Xiong, Xin, et al.
Publicado: (2022)

Clinical evaluation of a new serum tumour marker CA 242 in pancreatic carcinoma.
por: Pasanen, P. A., et al.
Publicado: (1992)

CA125 in ovarian tumour tissue at second laparotomy.
por: Maughan, T. S., et al.
Publicado: (1989)

Vascularisation Pattern of Chronic Pancreatitis Compared with Pancreatic Carcinoma: Results from Contrast-Enhanced Endoscopic Ultrasound
por: Hocke, Michael, et al.
Publicado: (2012)

Gastrointestinal cancer-associated antigen CA 19-9 in histological specimens of pancreatic tumours and pancreatitis.
por: Haglund, C., et al.
Publicado: (1986)

Pancreaticojejunostomy For Severe Symptomatic Chronic Pancreatitis
por: Denton, G. W. L., et al.
Publicado: (1992)

CA125 effects on humoral immunosuppression
por: Kline, J. Bradford, et al.
Publicado: (2017)

Is an increase in CA 125 in breast cancer patients an indicator of pleural metastases?
por: Jäger, W., et al.
Publicado: (1994)

CA19-9 as a marker for ovarian cancer: alone and in comparison with CA125.
por: Canney, P. A., et al.
Publicado: (1985)

The use of CA-50 radioimmunoassay in differentiating benign and malignant pancreatic disease.
por: Habib, N. A., et al.
Publicado: (1986)

Cannot write session to /tmp/vufind_sessions/sess_felr67m5gqac0j0i1iu89aoek6